The name ENSEM connotes innovations in integrating groundbreaking technologies to decipher structural ENSEMbles and kinetics for drug design.
ENSEM is a pioneering drug discovery and development company that leverages its unique Kinetic Ensemble™ platform to develop innovative small molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas.
ENSEM integrates computational and AI deep learning methodologies with advanced experimental techniques to identify non-obvious binding pockets and accelerate structure-based drug design, with a focus on high-value and difficult-to-drug targets.
Company Details
- Employees
- 26
- Founded
- -
- Address
- 880 Winter St,
- Industry
- Biotechnology
- Website
- http://www.ensemtx.com
- HQ
- Waltham, Massachusetts
Ensem Therapeutics Questions
Ensem Therapeutics's website is http://www.ensemtx.com
Ensem Therapeutics's LinkedIn profile is https://www.linkedin.com/company/ensemtx
Ensem Therapeutics has
26 employees.
View email and phone details for 26
employees at Ensem Therapeutics.
Ensem Therapeutics's industry is
Biotechnology
Ensem Therapeutics's top competitors are
Veritas Oncology, Llc,
Cbc Group,
Agios Pharmaceuticals,
Moma Therapeutics,
Atavistik Bio,
Kojin Therapeutics,
Mlab Biosciences,
Skyhawk Therapeutics,
Kymera Therapeutics,
Abio-X.
Ensem Therapeutics's categories are Biotechnology
Ensem Therapeutics's founding year is 2021
